YN251797 Aprotinin 9087-70-1

Aprotinin is abovine pancreatic trypsin inhibitor (BPTI)inhibitor which inhibitstrypsin and chymotrypsinwith Kis of 0.06 pM and 9nM, respectively.

YN251494 Pentagalloylglucose 14937-32-7

1,2,3,4,6-Pentagalloylglucose(PGG) and gallic acid from Pistacia lentiscus have antimutagenic and antioxidant activities. PGG possesses potent anti-proliferative and anti-invasive effects, it also has inhibition of inducible nitric ...

YN251543 Harringtonine 26833-85-2

Harringtonine, a natural Cephalotaxus alkaloid, is an inhibitor of protein synthesis.

YN250951 Nitazoxanide 55981-09-4

Nitazoxanide is a synthetic nitrothiazolyl-salicylamide derivative and an antiprotozoal agent. (IC50 for canine influenza virus ranges from 0.17 to 0.21 μM)

YN250612 Umifenovir hydrochloride 131707-23-8

Arbidol HCl is a broad-spectrum antiviral compound that blocks viral fusion, used in treatment of influenza and other respiratory viral infections.

YN251518 Dehydroandrographolide 134418-28-3

Dehydroandrographolide, isolated from Andrographis paniculata (Burm. F.) Nees (Chuan-xin-lian), is a novel TMEM16A inhibitor and possesses multiple pharmacological activities, including anti-inflammation, anti-cancer, anti-bacter...

YN250297 Iniparib 160003-66-7

Iniparib (BSI-201) is a PARP1 inhibitor with demonstrated effectiveness in triple-negative breast cancer (TNBC). Phase 3.

YN250694 Oseltamivir phosphate 204255-11-8

Oseltamivir Phosphate is a potent and selective inhibitor of the neuraminidase that is essential for replication of influenza A and B viruses, used to prevent influenza.

YN250099 Emricasan 254750-02-2

Emricasan is a potent irreversible pan-caspase inhibitor.

YN250595 Favipiravir 259793-96-9

Favipiravir (T-705) is a potent and selective RNA-dependent RNA polymerase inhibitor, used to treat influenza virus infections.

YN250337 Pimodivir 1629869-44-8

Pimodivir (VX-787) is an orally bioavailable inhibitor ofinfluenza A virus polymerasesthrough interaction with the viralPB2subunit.

YN250506 EIDD-2801 2349386-89-4

EIDD-2801 is an orally bioavailable prodrug of the ribonucleoside analog β-d-N⁴-hydroxycytidine (NHC; EIDD-1931) with broad-spectrum antiviral activity against SARS-CoV-2, MERS-CoV, <...